Semantic Definition Differences Not Inconsistent With Claim Construction
Client Alert | 1 min read | 01.30.08
In Innogenetics, N.V. v Abbott Laboratories (Nos. 2007-1145, -1161, January 17, 2008) the Federal Circuit reverses a district court’s JMOL that a claim was not anticipated, and remands for a new trial. The patent technology at issue relates to diagnostic tools for detecting and classifying hepatitis C types using specific short strands of nucleic acids, “probes”, that bind to target DNA. Innogenetics sued Abbott for patent infringement. At trial, Abbott’s expert testified that the Resnick patent anticipated claim 1 of Innogenetics’ patent, and specifically that the Resnick patent disclosed probes that “distinguish” between two hepatitis C types. The word “distinguish” was objected to by Innogenetics as inappropriate, arguing that Abbott’s expert report defined “a method of genotyping” as the process of “detecting and classifying.”
The district court construed “method of genotyping,” to mean a method that “distinguishes” among types. Before the case went to the jury, the district court granted JMOL of no anticipation based on its determination that Abbott’s expert testimony “rested on an inaccurate understanding of the construction of the limitation genotyping.” Abbott’s motion for a new trial was denied.
Using an abuse of discretion review standard, the Federal Circuit finds that the district court’s determination that the expert’s testimony was tainted by an inaccurate understanding of the term genotyping is clearly erroneous. Despite the semantical difference, the panel discerns no difference in the meaning between the definitions used by the expert and the one adopted by the district court, and finds that the expert’s failure to use the district court’s exact word does not change the substance of his testimony or render it inapplicable.
Insights
Client Alert | 5 min read | 06.04.26
EU Pay Transparency Directive: The Transposition Deadline is Looming — What Now?
Three years have passed since the EU Pay Transparency Directive ("PTD") came into existence, and it now appears highly likely that very few EU Member States will have fully transposed its provisions into national law by the 7 June 2026 deadline. For employers operating across the EU, this creates a deeply uncomfortable question: what are your obligations right now?
Client Alert | 4 min read | 06.04.26
Surveillance Pricing Update: California’s Sweeping AB 2564 Passes Assembly and Heads to Senate
Client Alert | 4 min read | 06.04.26
USTR Proposes Sweeping Tariffs as Part of Section 301 Forced Labor Import Enforcement Investigation
Client Alert | 6 min read | 06.03.26
Executive Order Creates Voluntary Regulatory Regime of Frontier AI Models
